DANIEL ANDERSON: Open Payments
NPI 1033267166 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 4 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Abbott Laboratories | 2 | $38 |
Products named: CAPLYTA, ABILIFY MAINTENA, AVEIR.
Industry payments across CA — which companies pay providers there.
